DAMORA THERAPEUTICS INC (DMRA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$30.06+7.36%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · DMRA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 74.1 | 26.9 | 6.4 | 23.8 | 48.2 | 38.5 | 24.6 |
| Operating Income | (270.7) | (210.9) | (22.3) | (39.9) | (61.2) | (52.2) | (33.6) |
| Earnings from Continuing Operations | |||||||
| Other Non-Operating Income / Expenses | 8.2 | 1.1 | 0.9 | 1.6 | (0.4) | 0.5 | (1.2) |
| EBT, Incl. Unusual Items | (262.5) | (209.8) | (21.4) | (38.3) | (61.6) | (51.8) | (34.8) |
| Income Tax Expense | — | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (262.8) | (209.8) | (21.4) | (38.3) | (61.6) | (51.8) | (34.8) |
| Per Share | |||||||
| Basic EPS | (4.30) | 3.98 | (18.53) | (36.08) | (2.43) | (2.05) | — |
| Diluted EPS | (4.30) | 3.98 | (18.53) | (36.08) | (2.43) | (2.05) | — |
| Dividend per Share | — | — | — | — | — | 0.00 | 0.00 |
| Basic Weighted Avg Shares | 61.1 | 1.4 | 1.2 | 1.1 | 25.4 | 25.3 | — |
| Diluted Weighted Avg Shares | 61.1 | 1.4 | 1.2 | 1.1 | 25.4 | 25.3 | — |
| Supplemental | |||||||
| EBIT | (270.7) | (210.9) | (22.3) | (39.9) | (61.2) | (52.2) | (33.6) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.